AAAAAA

   
Results: 1-19 |
Results: 19
PHARMACOKINETICS OF LUBELUZOLE (PROSYNAP) AFTER SINGLE INTRAVENOUS DOSES IN HEALTHY-SUBJECTS
Authors: VANDEVELDE V CRABBE R VANPEER A WOESTENBORGHS R VANOSSELAER N HANTSON L HEYKANTS J
Citation: V. Vandevelde et al., PHARMACOKINETICS OF LUBELUZOLE (PROSYNAP) AFTER SINGLE INTRAVENOUS DOSES IN HEALTHY-SUBJECTS, International journal of clinical pharmacology and therapeutics, 36(9), 1998, pp. 490-493
POPULATION ANALYSIS OF THE NON-LINEAR RED-BLOOD-CELL PARTITIONING ANDTHE CONCENTRATION-EFFECT RELATIONSHIP OF DRAFLAZINE FOLLOWING VARIOUSINFUSION RATES
Authors: SNOECK E PIOTROVSKIJ V JACQMIN P VANPEER A DANHOF M DONCK KV WOESTENBORGHS R VANBELLE H VANBORTEL L VANGOOL R DUPONT AG HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NON-LINEAR RED-BLOOD-CELL PARTITIONING ANDTHE CONCENTRATION-EFFECT RELATIONSHIP OF DRAFLAZINE FOLLOWING VARIOUSINFUSION RATES, British journal of clinical pharmacology, 43(6), 1997, pp. 603-612
POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS
Authors: SNOECK E PIOTROVSKIJ V JACQMIN P LINS RL VANPEER A DANHOF M WOESTENBORGHS R VANGOOL R DUPONT AG HEYKANTS J
Citation: E. Snoeck et al., POPULATION ANALYSIS OF THE NONLINEAR RED-BLOOD-CELL PARTITIONING OF DRAFLAZINE FOLLOWING VARIOUS INFUSION DURATIONS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 57-63
LOCATION OF THE HYDROXYL FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOL IN DIFFERENT ANIMAL SPECIES AND HUMAN-SUBJECTS AS DETERMINED BYONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DIODE-ARRAY DETECTION
Authors: HENDRICKX J BOCKX M ZWIJSEN C BORGMANS C MANNENS G MEULDERMANS W HEYKANTS J
Citation: J. Hendrickx et al., LOCATION OF THE HYDROXYL FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOL IN DIFFERENT ANIMAL SPECIES AND HUMAN-SUBJECTS AS DETERMINED BYONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DIODE-ARRAY DETECTION, Journal of chromatography, 729(1-2), 1996, pp. 341-354
THE IMPLICATIONS OF NONLINEAR RED-BLOOD-CELL PARTITIONING FOR THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NUCLEOSIDE TRANSPORT INHIBITOR DRAFLAZINE
Authors: SNOECK E JACQMIN P VANPEER A DANHOF M VERDONCK K VANBELLE H WOESTENBORGHS R CRABBE R VANGOOL R DUPONT A HEYKANTS J
Citation: E. Snoeck et al., THE IMPLICATIONS OF NONLINEAR RED-BLOOD-CELL PARTITIONING FOR THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NUCLEOSIDE TRANSPORT INHIBITOR DRAFLAZINE, British journal of clinical pharmacology, 42(5), 1996, pp. 605-613
INFLUENCE OF AGE, RENAL AND LIVER IMPAIRMENT ON THE PHARMACOKINETICS OF RISPERIDONE IN MAN
Authors: SNOECK E VANPEER A SACK M HORTON M MANNENS G WOESTENBORGHS R MEIBACH R HEYKANTS J
Citation: E. Snoeck et al., INFLUENCE OF AGE, RENAL AND LIVER IMPAIRMENT ON THE PHARMACOKINETICS OF RISPERIDONE IN MAN, Psychopharmacology, 122(3), 1995, pp. 223-229
THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW
Authors: HEYKANTS J VANPEER A VANDEVELDE V SNOECK E MEULDERMANS W WOESTENBORGHS R
Citation: J. Heykants et al., THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW, Clinical pharmacokinetics, 29(4), 1995, pp. 221-230
REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS
Authors: LAVRIJSEN K VANDYCK D VANHOUDT J HENDRICKX J MONBALIU J WOESTENBORGHS R MEULDERMANS W HEYKANTS J
Citation: K. Lavrijsen et al., REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS, Drug metabolism and disposition, 23(3), 1995, pp. 354-362
PLASMA-PROTEIN BINDING OF RISPERIDONE AND ITS DISTRIBUTION IN BLOOD
Authors: MANNENS G MEULDERMANS W SNOECK E HEYKANTS J
Citation: G. Mannens et al., PLASMA-PROTEIN BINDING OF RISPERIDONE AND ITS DISTRIBUTION IN BLOOD, Psychopharmacology, 114(4), 1994, pp. 566-572
THE PHARMACOKINETICS OF RISPERIDONE IN HUMANS - A SUMMARY
Authors: HEYKANTS J HUANG ML MANNENS G MEULDERMANS W SNOECK E VANBEIJSTERVELDT L VANPEER A WOESTENBORGHS R
Citation: J. Heykants et al., THE PHARMACOKINETICS OF RISPERIDONE IN HUMANS - A SUMMARY, The Journal of clinical psychiatry, 55, 1994, pp. 13-17
THE METABOLISM AND EXCRETION OF RISPERIDONE AFTER ORAL-ADMINISTRATIONIN RATS AND DOGS
Authors: MEULDERMANS W HENDRICKX J MANNENS G LAVRIJSEN K JANSSEN C BRACKE J LEJEUNE L LAUWERS W HEYKANTS J
Citation: W. Meuldermans et al., THE METABOLISM AND EXCRETION OF RISPERIDONE AFTER ORAL-ADMINISTRATIONIN RATS AND DOGS, Drug metabolism and disposition, 22(1), 1994, pp. 129-138
THE METABOLIC CONVERSION OF THE PRO-DRUG LOPERAMIDE OXIDE TO LOPERAMIDE IN-VITRO AND IN-VIVO
Authors: LAVRIJSEN K MONBALIU J VANBEIJSTERVELDT L WOESTENBORGHS R MEULDERMANS W VERLINDEN M HEYKANTS J
Citation: K. Lavrijsen et al., THE METABOLIC CONVERSION OF THE PRO-DRUG LOPERAMIDE OXIDE TO LOPERAMIDE IN-VITRO AND IN-VIVO, Gastroenterology, 106(4), 1994, pp. 10000246-10000246
PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS IN PHASE-I PHASE-II OF DRUG DEVELOPMENT
Authors: VANPEER A SNOECK E HUANG ML HEYKANTS J
Citation: A. Vanpeer et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS IN PHASE-I PHASE-II OF DRUG DEVELOPMENT, European journal of drug metabolism and pharmacokinetics, 18(1), 1993, pp. 49-59
INSUFFICIENT KETOCONAZOLE CONCENTRATIONS IN PRETERM INFANTS WITH FUNGAL-INFECTIONS
Authors: VANDENANKER JN VANLINGEN RA KOSTER M HEYKANTS J SAUER PJJ
Citation: Jn. Vandenanker et al., INSUFFICIENT KETOCONAZOLE CONCENTRATIONS IN PRETERM INFANTS WITH FUNGAL-INFECTIONS, European journal of pediatrics, 152(6), 1993, pp. 538-538
ITRACONAZOLE PLASMA AND VAGINAL MUCOSAL LEVELS IN PATIENTS WITH CHRONIC VAGINAL CANDIDOSIS TREATED WITH ITRACONAZOLE 200MG ONCE-DAILY FOR 3CONSECUTIVE DAYS
Authors: GORLERO F LAROSA E CAUWENBERGH G WOESTENBORGHS R HEYKANTS J CILLI P DECECCO L
Citation: F. Gorlero et al., ITRACONAZOLE PLASMA AND VAGINAL MUCOSAL LEVELS IN PATIENTS WITH CHRONIC VAGINAL CANDIDOSIS TREATED WITH ITRACONAZOLE 200MG ONCE-DAILY FOR 3CONSECUTIVE DAYS, Drug investigation, 6(1), 1993, pp. 22-24
PHARMACOKINETICS OF ORALLY-ADMINISTERED LEVOCABASTINE IN PATIENTS WITH RENAL-INSUFFICIENCY
Authors: ZAZGORNIK J HUANG ML VANPEER A WOESTENBORGHS R HEYKANTS J STEPHEN A
Citation: J. Zazgornik et al., PHARMACOKINETICS OF ORALLY-ADMINISTERED LEVOCABASTINE IN PATIENTS WITH RENAL-INSUFFICIENCY, Journal of clinical pharmacology, 33(12), 1993, pp. 1214-1218
ABSORPTION, METABOLISM, AND EXCRETION OF RISPERIDONE IN HUMANS
Authors: MANNENS G HUANG ML MEULDERMANS W HENDRICKX J WOESTENBORGHS R HEYKANTS J
Citation: G. Mannens et al., ABSORPTION, METABOLISM, AND EXCRETION OF RISPERIDONE IN HUMANS, Drug metabolism and disposition, 21(6), 1993, pp. 1134-1141
DISCREPANCIES IN BIOASSAY AND CHROMATOGRAPHY DETERMINATIONS EXPLAINEDBY METABOLISM OF ITRACONAZOLE TO HYDROXYITRACONAZOLE - STUDIES OF INTERPATIENT VARIATIONS IN CONCENTRATIONS
Authors: HOSTETLER JS HEYKANTS J CLEMONS KV WOESTENBORGHS R HANSON LH STEVENS DA
Citation: Js. Hostetler et al., DISCREPANCIES IN BIOASSAY AND CHROMATOGRAPHY DETERMINATIONS EXPLAINEDBY METABOLISM OF ITRACONAZOLE TO HYDROXYITRACONAZOLE - STUDIES OF INTERPATIENT VARIATIONS IN CONCENTRATIONS, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2224-2227
PHARMACOKINETICS OF THE NOVEL ANTIPSYCHOTIC AGENT RISPERIDONE AND THEPROLACTIN RESPONSE IN HEALTHY-SUBJECTS
Authors: HUANG ML VANPEER A WOESTENBORGHS R DECOSTER R HEYKANTS J JANSEN AAI ZYLICZ Z VISSCHER HW JONKMAN JHG
Citation: Ml. Huang et al., PHARMACOKINETICS OF THE NOVEL ANTIPSYCHOTIC AGENT RISPERIDONE AND THEPROLACTIN RESPONSE IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 54(3), 1993, pp. 257-268
Risultati: 1-19 |